Genetic variants and abnormal processing of pre-miR-182, a circadian clock modulator, in major depression patients

Ester Saus1, Virginia Soria, Geòrgia Escaramís

  • 1Genes and Disease Program, Center for Genomic Regulation-UPF, and CIBER en Epidemiología y Salud Pública, Barcelona 08003, Catalonia, Spain.

Insights

A genetic variant in pre-microRNA-182 (miR-182) is linked to insomnia in major depression patients. This finding suggests a role for miR-182 in circadian rhythm disruption and major depression susceptibility.

Area of Science:

  • Genetics
  • Neuroscience
  • Molecular Biology

Background:

  • Circadian rhythm disruption is linked to major depression.
  • MicroRNAs (miRNAs) like miR-182 are known modulators of the circadian clock.
  • Previous studies suggest a link between miRNAs, circadian rhythm, and depression.

Purpose of the Study:

  • Investigate specific miRNAs and their target genes as potential predisposing factors for major depression (MD).
  • Examine the role of miR-182 and its genetic variants in MD pathophysiology, particularly in relation to insomnia and circadian rhythm disturbances.

Main Methods:

  • Performed mutational screening of miRNAs and their targets in 359 MD patients and 341 controls.
  • Utilized quantitative real-time polymerase chain reaction to assess miR-182 expression.
  • Employed luciferase reporter assays to evaluate the functional impact of miR-182 on target genes (ADCY6, CLOCK, DSIP).

Main Results:

  • A significant association was found between the rs76481776 polymorphism in pre-miR-182 and late insomnia in MD patients.
  • Overexpression of miR-182 was observed in cells with the mutated pre-miR-182 form.
  • Mutated miR-182 significantly reduced luciferase activity in target genes ADCY6, CLOCK, and DSIP.

Conclusions:

  • The T allele of the rs76481776 polymorphism in pre-miR-182 may contribute to circadian rhythm dysregulation in MD patients with insomnia.
  • Abnormal miR-182 processing could impact mature miR-182 levels and downstream gene expression, potentially influencing MD susceptibility.
  • This study highlights a potential genetic link between miR-182, circadian rhythms, and major depression.

Related Concept Videos

Circadian Rhythms and Gene Regulation02:19

Circadian Rhythms and Gene Regulation

The biological clock is involved in many aspects of regulating complex physiology in all animals. It was in 1935 when German zoologists, Hans Kalmus and Erwin Bünning, discovered the existence of circadian rhythm in Drosophila melanogaster. However, the internal molecular mechanisms behind the circadian clock remained a mystery until 1984, when Jeffrey C. Hall, Michael Rosbash, and Michael W. Young discovered the expression of the Per gene oscillating over a 24-hour cycle. In subsequent years,...
Circadian Rhythms and Gene Regulation02:19

Circadian Rhythms and Gene Regulation

The biological clock is involved in many aspects of regulating complex physiology in all animals. It was in 1935 when German zoologists, Hans Kalmus and Erwin Bünning, discovered the existence of circadian rhythm in Drosophila melanogaster. However, the internal molecular mechanisms behind the circadian clock remained a mystery until 1984, when Jeffrey C. Hall, Michael Rosbash, and Michael W. Young discovered the expression of the Per gene oscillating over a 24-hour cycle. In subsequent years,...
Human Genetics01:28

Human Genetics

Human genetics provides a profound framework for understanding the interplay between genetic predispositions and human psychology. At the heart of this discipline lies the study of how genes influence physical traits, behaviors, and susceptibility to diseases. Each person carries a unique genetic code that subtly or significantly shapes their psychological and behavioral landscape.
The complex relationship between genetics and psychology is observable through common biological components such...
Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu01:29

Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu

Genetic variations significantly influence drug response through pharmacokinetics, receptor interactions, and biologic milieu modifications. Pharmacokinetic alterations impact drug metabolism and clearance, affecting efficacy and toxicity. Variants in drug-metabolizing enzymes, such as CYP2C9 and CYP2C19, alter drug activation and elimination. For example, CYP2C9 loss-of-function variants require lower warfarin doses to prevent excessive bleeding, while CYP2C19 variants reduce clopidogrel...
Management of Insomnia01:19

Management of Insomnia

The sleep cycle, an integral part of human health, consists of several stages with distinct characteristics and functions. It begins with a transition from wakefulness to sleep, known as the light sleep phase, followed by the restorative deep sleep phase, essential for physical recovery and growth. The cycle concludes with the Rapid Eye Movement (REM) phase, characterized by high brain activity and vivid dreaming. Insomnia, a prevalent sleep disorder, involves difficulty falling asleep, staying...
Chronopharmacokinetics: Circadian Rhythms and Influence on Drug Response01:15

Chronopharmacokinetics: Circadian Rhythms and Influence on Drug Response

Circadian rhythms are cyclic changes that are crucial in plasma drug concentrations. Various standard circadian parameters, including core body temperature, heart rate, and other cardiovascular factors, directly impact disease states and the therapeutic response to drug therapy.
The time of drug administration is an important factor to consider, as it can influence the toxic dose of a drug. For example, a study conducted by Prins et al. in 1997 examined the effects of the timing of...